Form 4: John Patience Acquires Restricted Stock Units and Stock Options in Biodesix Inc.

John Patience, Chairman of Biodesix Inc., reports the acquisition of restricted stock units and stock options.

Summary

• John Patience, Chairman of Biodesix Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 20, 2025, Patience acquired 68,621 restricted stock units (RSUs) and 42,010 stock options.
• The RSUs will vest in three equal installments on June 30, September 30, and December 31, 2025, contingent upon continued service with the Issuer.
• The stock options, with an exercise price of $0.2708, also vest in three equal installments on June 30, September 30, and December 31, 2025, subject to continued service.
• Following the reported transactions, Patience directly owns 68,621 RSUs and 42,010 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard regulatory filing related to stock options and restricted stock units. It doesn't inherently indicate positive or negative company performance.

Positives

• The acquisition of RSUs and stock options suggests confidence in the future performance of Biodesix Inc.
• The vesting schedule incentivizes continued service and commitment from John Patience.

Future Outlook

The vesting schedule of the RSUs and stock options suggests a focus on long-term value creation and retention of key personnel.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading and provide investors with information about the holdings and transactions of company insiders.

Stakeholder Impact

• The acquisition of RSUs and stock options by a key executive can signal confidence to shareholders.
• The vesting schedule incentivizes the executive to remain with the company, which can benefit employees and other stakeholders.

Key Dates

Keywords

Biodesix Inc, John Patience, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Options, Vesting